How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

7,519 results for

Adenomyosis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. The impact of endometriosis on early pregnancy and that of pregnancy on endometriomas. A systemic review and meta-analysis.

The impact of endometriosis on early pregnancy and that of pregnancy on endometriomas. A systemic review and meta-analysis. Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

22. Spontaneous fertility after expectant or surgical management of rectovaginal endometriosis in women with or without ovarian endometrioma: a retrospective analysis. Full Text available with Trip Pro

Spontaneous fertility after expectant or surgical management of rectovaginal endometriosis in women with or without ovarian endometrioma: a retrospective analysis. To investigate spontaneous pregnancy rate (SPRs) of women with rectovaginal endometriosis (RV) with/without ovarian endometrioma (OMA) and treated with the use of expectant or surgical management.Retrospective study.University hospital.The study included patients with RV with or without OMA who tried to conceive spontaneously for 1

2017 Fertility and Sterility

23. The Effect of Surgery for Endometriomas on Fertility Full Text available with Trip Pro

with endometriosis and are often associated with the severe form of the disease. , While the pathognomonic mechanisms of endometriosis per se remain elusive, it is widely believed that most endometriotic lesions develop from retrograde menstruation and are possibly associated with immune dysfunction, which can interfere with endometrial implant clearance. Endometriotic ovarian cysts (known as ‘endometriomas’) are mostly thought to occur through invagination of endometriotic tissue/cells through the ovarian (...) distortion and reduced endometrial receptivity, leading to compromised oocyte and embryo quality, and ovarian reserve, but the precise mechanism has yet to be determined. 3 Potential mechanisms for endometrioma‐associated infertility 3.1 Chronic inflammation Endometriosis is associated with dysregulation of the immune system. Peritoneal fluid from women with endometriosis has been found to contain increased numbers of immune cells, including macrophages, and mast, natural killer and T cells, as well

2017 Royal College of Obstetricians and Gynaecologists

24. Adenomyosis and Myomata: Risks, Problems, and Complications in Diagnosis and Therapy of Adenomyosis and Myomata Full Text available with Trip Pro

, Frankfurt, Germany. eng Editorial 2018 08 06 United States Biomed Res Int 101600173 0 Receptors, Estrogen IM Adenomyosis classification diagnosis therapy Endometriosis Female Humans Leiomyoma complications diagnosis therapy Myoma complications diagnosis therapy Pregnancy Receptors, Estrogen Uterine Neoplasms complications diagnosis therapy 2018 06 03 2018 06 05 2018 9 4 6 0 2018 9 4 6 0 2018 12 12 6 0 epublish 30175136 10.1155/2018/5952460 PMC6106914 (...) Adenomyosis and Myomata: Risks, Problems, and Complications in Diagnosis and Therapy of Adenomyosis and Myomata 30175136 2018 12 11 2018 12 11 2314-6141 2018 2018 BioMed research international Biomed Res Int Adenomyosis and Myomata: Risks, Problems, and Complications in Diagnosis and Therapy of Adenomyosis and Myomata. 5952460 10.1155/2018/5952460 De Wilde Rudy Leon RL 0000-0001-5759-9745 Department of Gynecology, Obstetrics and Gynecological Oncology, University Hospital for Gynecology, Pius

2018 BioMed research international

25. EFFECT OF PELVIC ENDOMETRIOSIS, ENDOMETRIOMAS AND RECURRENT ENDOMETRIOMAS ON IVF-ET/ICSI OUTCOMES Full Text available with Trip Pro

EFFECT OF PELVIC ENDOMETRIOSIS, ENDOMETRIOMAS AND RECURRENT ENDOMETRIOMAS ON IVF-ET/ICSI OUTCOMES Endometriosis, the most common gynecological disorder, is a challenging disease observed in 20% - 40% of subfertile women.380 women were divided into four groups. Group A consisted of 176 women with pelvic endometriosis. Group B consisted of 125 women who had previously undergone a laparoscopic endometrioma cystectomy. Group C consisted of 38 women with recurrent endometriomas without aspiration (...) embryos, implantation and pregnancy rates were similar in Groups C and D.Pelvic endometriosis had a less adverse effect on ovarian reserve than endometrioma. No advantage was found in transvaginal aspiration for recurrent endometriomas before IVF-ET/ICSI.

2016 Materia socio-medica Controlled trial quality: uncertain

26. Painful endometriosis: initial treatment options

Painful endometriosis: initial treatment options Prescrire IN ENGLISH - Spotlight ''Painful endometriosis: initial treatment options'', 1 March 2020 {1} {1} {1} | | > > > Painful endometriosis: initial treatment options Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Painful endometriosis: initial treatment options In the absence of urinary (...) or intestinal symptoms, and if the patient is not planning to become pregnant any time soon, first try analgesics such as NSAIDs or paracetamol. Hormonal contraception or a levonorgestrel intrauterine device are other options. Endometriosis, i.e. the abnormal presence of clumps of uterine mucous membrane cells outside the uterus, is a frequent cause of pelvic pain during menstruation. In some women, endometriosis is very painful and debilitating. Endometriosis does not appear to get worse over time

2020 Prescrire

27. Endometriosis

Endometriosis Endometriosis - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Search Select language Endometriosis Last reviewed: December 2019 Last updated: March 2019 Summary Chronic inflammatory condition defined by endometrial stroma and glands found outside of the uterine cavity. The most common sites affected are the pelvic peritoneum and ovaries. May present incidentally in asymptomatic patients, or more (...) ), and surgical destruction of lesions. Controlled ovarian hyper-stimulation and IVF may be considered for patients with sub-fertility. Individualised care for patients with pelvic pain should incorporate a multi-disciplinary evaluation and treatment plan that focuses on limiting the risk of recurrence and improving quality of life. Definition Endometriosis is defined as the presence of endometrial glands and stroma outside the endometrial cavity and uterine musculature. Surgical appearance varies

2019 BMJ Best Practice

28. Endometriosis: diagnosis and management

, consider referral for further assessment and investigation. Ultr Ultrasound asound 1.5.2 Consider transvaginal ultrasound: to investigate suspected endometriosis even if the pelvic and/or abdominal examination is normal to identify endometriomas and deep endometriosis involving the bowel, bladder or ureter. 1.5.3 If a transvaginal scan is not appropriate, consider a transabdominal ultrasound scan of the pelvis. Endometriosis: diagnosis and management (NG73) © NICE 2019. All rights reserved. Subject (...) a biopsy of suspected endometriosis: Endometriosis: diagnosis and management (NG73) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 9 of 24to confirm the diagnosis of endometriosis (be aware that a negative histological result does not exclude endometriosis) to exclude malignancy if an endometrioma is treated but not excised. 1.5.13 If a full, systematic laparoscopy is performed and is normal, explain to the woman

2017 National Institute for Health and Clinical Excellence - Clinical Guidelines

29. Uterine artery embolisation for treating adenomyosis (IPG473)

, in December, 2013. Description Adenomyosis is a benign condition characterised by the presence of ectopic endometrial glands and stroma within the myometrium. It frequently occurs coincidentally with fibroids. Adenomyosis may cause no symptoms but some women with adenomyosis experience heavy, prolonged menstrual bleeding with severe cramps, pelvic pain and discomfort. Treatment for symptomatic adenomyosis includes anti-inflammatory medications, hormone therapy and endometrial ablation. For severe symptoms (...) Uterine artery embolisation for treating adenomyosis (IPG473) Overview | Uterine artery embolisation for treating adenomyosis | Guidance | NICE Uterine artery embolisation for treating adenomyosis Interventional procedures guidance [IPG473] Published date: December 2013 Share Save Guidance The National Institute for Health and Care Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Uterine Artery Embolisation for treating adenomyosis

2013 National Institute for Health and Clinical Excellence - Interventional Procedures

30. Elagolix (Orilissa) - for the treatment of moderate to severe pain associated with endometriosis

Elagolix (Orilissa) - for the treatment of moderate to severe pain associated with endometriosis Search Page - Drug and Health Product Register Language selection Search and menus Search Search website Search Topics menu You are here: Summary Basis of Decision - - Health Canada Expand all Summary Basis of Decision (SBD) for Contact: Summary Basis of Decision (SBD) documents provide information related to the original authorization of a product. The for is located below. Recent Activity for SBDs

2019 Health Canada - Drug and Health Product Register

31. Impact of haemostatic sealant versus electrocoagulation on ovarian reserve after laparoscopic ovarian cystectomy of ovarian endometriomas: a randomised controlled trial Full Text available with Trip Pro

Impact of haemostatic sealant versus electrocoagulation on ovarian reserve after laparoscopic ovarian cystectomy of ovarian endometriomas: a randomised controlled trial To evaluate the effect of haemostatic sealant compared with bipolar coagulation on ovarian reserve after laparoscopic cystectomy for ovarian endometriomas.Patient-blinded, randomised controlled trial.University-affiliated tertiary hospital.Women aged 18-40 years with 3-8 cm unilateral or bilateral endometriomas.Ninety-four (...)  ± 4.92 years underwent laparoscopic cystectomy for ovarian endometriomas. The average diameter of the endometrioma was 4.21 ± 1.38 cm. The increase in antral follicle count of the affected ovaries at 3 months in the intervention group (+2.36 ± 0.37) was significantly (P = 0.013) higher than that in the control group (+1.08 ± 0.36). Repeated measures analysis of variance revealed significant effect with time (P < 0.001) and of interaction of group × time (P = 0.029) for affected ovary antral follicle

2019 EvidenceUpdates

32. Endometriosis

Endometriosis Endometriosis - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Endometriosis Last reviewed: February 2019 Last updated: March 2019 Summary Chronic inflammatory condition defined by endometrial stroma and glands found outside of the uterine cavity. The most common sites affected are the pelvic peritoneum and ovaries. May present incidentally in asymptomatic patients, or more commonly in women (...) of lesions. Controlled ovarian hyper-stimulation and IVF may be considered for patients with sub-fertility. Individualised care for patients with pelvic pain should incorporate a multi-disciplinary evaluation and treatment plan that focuses on limiting the risk of recurrence and improving quality of life. Definition Endometriosis is defined as the presence of endometrial glands and stroma outside the endometrial cavity and uterine musculature. Surgical appearance varies significantly from superficial

2018 BMJ Best Practice

33. Endometriosis factsheet

diagnosed. Endometriosis can often be confused with or misdiagnosed as IBS (irritable bowel syndrome). It is important that women receive a early diagnosis, or working diagnosis, of endometriosis even if hormonal treatments appear to be working, as women need to understand that they have a long term, chronic condition and the impact this might have on their future and their fertility. What is endometriosis? Endometriosis is defined as the presence of endometrial-like tissue outside the uterus, which (...) arrangements and seek advice from an endometriosis clinical nurse specialist: • if there is uncertainty over the diagnosis • if a women requests referral • if the woman has fertility problems • if surgical and medical management of endometriosis is required6 • if complex/severe endometriosis is suspected – for example, endometriomas or where endometriosis is affecting the bowel (Quality Standard 2018) • if initial hormonal treatment for endometriosis is not effective, not tolerated or contraindicated (NICE

2018 Royal College of Nursing

34. Endometriosis

/terms-and- conditions#notice-of-rights). Page 2 of 25Contents Contents Overview 4 Who is it for? 4 Recommendations 5 1.1 2017 2. Recommendations for surgical treatment of endometriosis . Part 1: Ovarian Endometrioma Recommendations for the Surgical Treatment of Endometriosis . Part 1: Ovarian Endometrioma †‡¶ | Human Reproduction Open | Oxford Academic We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change (...) your cookie settings at any time. Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter (...) search input Article Navigation Close mobile search navigation Article navigation 2017 Article Contents Article Navigation Recommendations for the Surgical Treatment of Endometriosis . Part 1: Ovarian Endometrioma Working group of ESGE, ESHRE and WES Search for other works by this author on: Ertan Saridogan Institute for Women's Health , University College Hospital

2018 Trip Latest and Greatest

35. Elagolix sodium (Orilissa) - For the management of moderate to severe pain associated with endometriosis

Elagolix sodium (Orilissa) - For the management of moderate to severe pain associated with endometriosis Drug Approval Package: Orilissa (elagolix sodium) U.S. Department of Health and Human Services Search FDA Submit search Drug Approval Package: Orilissa (elagolix sodium) Company: AbbVie Inc. Application Number: 210450 Approval Date: 07/23/2018 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. FDA Approval Letter and Labeling (PDF

2018 FDA - Drug Approval Package

37. The reproductive life course impact of endometriosis and adenomyosis

The reproductive life course impact of endometriosis and adenomyosis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2017 PROSPERO

38. A mixed method systematic review evaluating the non-surgical, non-pharmacological interventions that aim to improve the quality of life for women with chronic pelvic pain due to adenomyosis and endometriosis

A mixed method systematic review evaluating the non-surgical, non-pharmacological interventions that aim to improve the quality of life for women with chronic pelvic pain due to adenomyosis and endometriosis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files

2017 PROSPERO

39. Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis. Full Text available with Trip Pro

Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis. To evaluate the efficacy and feasibility of levonorgestrel-releasing intrauterine device (LNG-IUD) use longer than 5 years in women with adenomyosis.Data were retrospectively collected from patients who were treated with LNG-IUD longer than 5 years at the Chungnam National University hospital for adenomyosis diagnosed with ultrasonography from January 2006 to November 2013 (...) .A total of 131 patients who were diagnosed with adenomyosis had treated with LNG-IUD longer than 5 years. The mean duration of keeping 1 device without replacement was 58.35 ± 15.98 months, and total duration of LNG-IUD treatment was 83.86 ± 23.88 months. A total of 51 patients stopped using LNG-IUD after 5 years and the mean age at the time of LNG-IUD removal was 52.46 ± 6.9. LNG-IUD treatment had a significant effect on both menorrhagia and dysmenorrhea starting from the first month of insertion (P

2020 Medicine

40. Adjuvant therapy of Chinese herbal medicine for the treatment of adenomyosis: A protocol for systematic review. Full Text available with Trip Pro

Adjuvant therapy of Chinese herbal medicine for the treatment of adenomyosis: A protocol for systematic review. Adenomyosis is benign gynecologic condition with complex etiologies. Common symptoms associated with adenomyosis (AM) include menorrhagia, dysmenorrhea, chronic pelvic pain, metrorrhagia, and dyspareunia. Although Chinese herbal medicine (CHM) has often been utilized for managing AM in clinical practice in China, evidence regarding its efficacy is lacking. This systematic review (...) outcomes will be relief in pain and uterine bleeding. The secondary outcomes include the adverse effects, CA125 variation in peripheral blood, reduction in uterine volume, and endometrial thickness. We will use RevMan V.5.3 to conduct the meta-analysis, if possible. If it is not allowed, a descriptive analysis will be conducted. We will use risk ratio with 95% confidence interval for dichotomous data and the mean difference for continuous data.This study will provide the latest analysis

2020 Medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>